Simulations also suggested that the checkpoints 4-1BB and OX40 may be most influential when designing immune-modulatory BsAbs, possibly due to their immuno-activating functions, as BsAbs that include either of these two checkpoints as one activating arm were always predicted to have superior anti-tumor efficacy (Figure 5B). Here, TNFRSF4 is linked to neoplasm.